Perspective Therapeutics, Inc. (CATX)
2.17
-0.17
(-7.26%)
USD |
NYAM |
Oct 16, 16:00
2.21
+0.04
(+1.84%)
After-Hours: 20:00
Perspective Therapeutics Net Income (TTM) : -116.63M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -116.63M |
| March 31, 2026 | -111.65M |
| December 31, 2025 | -103.64M |
| September 30, 2025 | -106.26M |
| June 30, 2025 | -95.41M |
| March 31, 2025 | -84.68M |
| December 31, 2024 | -78.33M |
| September 30, 2024 | -47.79M |
| June 30, 2024 | -42.16M |
| March 31, 2024 | -29.79M |
| September 30, 2023 | -20.04M |
| June 30, 2023 | -11.82M |
| March 31, 2023 | -3.934M |
| June 30, 2022 | -7.272M |
| March 31, 2022 | -6.255M |
| December 31, 2021 | -5.653M |
| September 30, 2021 | -4.917M |
| June 30, 2021 | -3.387M |
| March 31, 2021 | -3.514M |
| December 31, 2020 | -3.314M |
| September 30, 2020 | -3.343M |
| June 30, 2020 | -3.446M |
| March 31, 2020 | -3.353M |
| December 31, 2019 | -3.935M |
| September 30, 2019 | -4.452M |
| Date | Value |
|---|---|
| June 30, 2019 | -5.144M |
| March 31, 2019 | -6.407M |
| December 31, 2018 | -6.612M |
| September 30, 2018 | -6.661M |
| June 30, 2018 | -6.699M |
| March 31, 2018 | -6.195M |
| December 31, 2017 | -6.223M |
| September 30, 2017 | -6.21M |
| June 30, 2017 | -6.162M |
| March 31, 2017 | -5.493M |
| December 31, 2016 | -5.328M |
| September 30, 2016 | -5.190M |
| June 30, 2016 | -4.711M |
| March 31, 2016 | -4.561M |
| December 31, 2015 | -4.319M |
| September 30, 2015 | -3.914M |
| June 30, 2015 | -3.681M |
| March 31, 2015 | -4.324M |
| December 31, 2014 | -5.454M |
| September 30, 2014 | -5.474M |
| June 30, 2014 | -5.959M |
| March 31, 2014 | -5.275M |
| December 31, 2013 | -3.906M |
| September 30, 2013 | -4.134M |
| June 30, 2013 | -3.857M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Anika Therapeutics, Inc. | -3.121M |
| MiMedx Group, Inc. | 6.239M |
| ABVC BioPharma, Inc. | -7.600M |
| Enovis Corp. | -1.099B |
| Edwards Lifesciences Corp. | 978.60M |